Conatus Pharmaceuticals Inc. (CNAT)

[realfast95]

if this twitter user is right, it's $16

don marcel? @To4ortunates 2h2 hours ago

$CNAT Seaport Global analyst Vernon Bernardino initiated Conatus with a Buy and $16 price target. He also initiated $AUPH Buy PT=$10



bio
Vernon Bernardino

http://www.businesswire.com/news/home/20171006005119/en/Seaport-Global-Securities-Expands-Research-Healthcare-Sector


Seaport Global Securities Expands Research into Healthcare Sector

Vernon Bernardino Joins as Managing Director and Senior Equity Analyst,
Initiates Coverage of Biotechnology and Specialty Pharmaceuticals Sector

October 06, 2017 09:00 AM Eastern Daylight Time

NEW YORK--(BUSINESS WIRE)--Seaport Global Securities LLC (“Seaport Global”), a full-service investment bank, today announced that it has expanded its equity research team with the addition of Managing Director and Senior Equity Analyst Vernon Bernardino, who is launching coverage of the biotechnology and specialty pharmaceuticals sector today. Vernon brings 14 years of investment research experience and 11 years of industry experience primarily as a research scientist for drug development. His principal focus is on biotechnology, biopharmaceutical, specialty pharmaceutical and immunotherapy companies that focus on treatment of cancer, infectious diseases and cell-based therapies targeting inflammatory disorders and vascular diseases.

“We see numerous opportunities in the healthcare sector for which we offer valuable insight to help our clients stay ahead and take advantage of key drivers and trends. We look forward to continuing to expand our healthcare team.”
Tweet this

Most recently, Vernon was a Senior Analyst covering biotechnology and specialty pharmaceutical companies at FBR & Co. He was previously at UBS, Rodman & Renshaw, and Dawson James. He also previously worked at Global Hunter Securities, predecessor to Seaport Global Securities’ equities division. Earlier in his career, Bernardino was a buy-side analyst at Nicholas Applegate Capital Management, and founded the strategic advisory group Oceros Advisors LP. Vernon holds a bachelor's degree from Rutgers University and a master's degree in business administration (finance) from the University of San Diego.

Ed Lainfiesta, Managing Partner of Seaport Global, said, “We are pleased to have Vernon join the equity research team and launch our healthcare research product. He brings significant industry and Wall Street experience that is critical to this highly dynamic industry.” He continued, “We see numerous opportunities in the healthcare sector for which we offer valuable insight to help our clients stay ahead and take advantage of key drivers and trends. We look forward to continuing to expand our healthcare team.”

About Seaport Global Securities

Seaport Global Securities LLC (www.seaportglobal.com) is a full-service investment bank that offers investment banking, capital markets, financial advisory, sales, trading and research services.

Co-headquartered in New York and New Orleans with offices across the US and in Europe, Seaport Global pairs its extensive knowledge and relationships in the energy, industrials, mining and metals, chemicals, shipping and healthcare industries, with a large platform of equity and fixed income sales, trading and research. The firm’s forward-thinking practitioners, backed by decades of experience, focus on meeting clients’ goals in all business and economic cycles.

Contacts

Seaport Global Securities LLC
Lisa Weiss
Director of Human Resources
212-601-9071
[e-mail]